Literature DB >> 9100742

Pathways to depressed mood for midlife women: observations from the Seattle Midlife Women's Health Study.

N F Woods1, E S Mitchell.   

Abstract

The purpose of this study was to develop and test a multidimensional model of depressed mood experienced by women during midlife. Three pathways to depressed mood were tested for their explanatory power, including menopausal transition, stressful life context, and health status pathways in a multiethnic sample (N = 337). Multiple measures for each variable in the three paths included the CESD and SCL 90 depression scales, menopausal changes questions, vasomotor symptoms rated in a daily health diary. Life Events Scale, Attitudes toward Menopause and Attitudes toward Aging Scales, and chronic health problems and perceived health ratings. The stressful life context pathway was most influential in accounting for depressed mood. Health status had a direct effect on depressed mood and an indirect effect through stress. The menopausal changes pathway had little explanatory power. These results support the need for clinicians to look beyond menopausal status to the broader context of midlife women's lives.

Entities:  

Mesh:

Year:  1997        PMID: 9100742     DOI: 10.1002/(sici)1098-240x(199704)20:2<119::aid-nur4>3.0.co;2-n

Source DB:  PubMed          Journal:  Res Nurs Health        ISSN: 0160-6891            Impact factor:   2.228


  19 in total

Review 1.  Depression During and After the Perimenopause: Impact of Hormones, Genetics, and Environmental Determinants of Disease.

Authors:  Joyce T Bromberger; Cynthia Neill Epperson
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

Review 2.  Physical Activity and Physical Function: Moving and Aging.

Authors:  Sheila A Dugan; Kelley Pettee Gabriel; Brittney S Lange-Maia; Carrie Karvonen-Gutierrez
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

3.  Effects of reproductive history on symptoms of menopause: a brief report.

Authors:  Deborah B Nelson; Mary D Sammel; Freda Patterson; Hui Lin; Clarisa R Gracia; Ellen W Freeman
Journal:  Menopause       Date:  2011-10       Impact factor: 2.953

4.  Risk assessment for psychological disorders in postmenopausal women.

Authors:  Anuradha Tamaria; Rekha Bharti; Manjula Sharma; Rupali Dewan; Garima Kapoor; Abha Aggarwal; Achla Batra; Aruna Batra
Journal:  J Clin Diagn Res       Date:  2013-12-15

5.  Racial/ethnic differences in the prevalence of depressive symptoms among middle-aged women: The Study of Women's Health Across the Nation (SWAN).

Authors:  Joyce T Bromberger; Sioban Harlow; Nancy Avis; Howard M Kravitz; Adriana Cordal
Journal:  Am J Public Health       Date:  2004-08       Impact factor: 9.308

Review 6.  Reproductive aging, sex steroids, and mood disorders.

Authors:  Veronica Harsh; Samantha Meltzer-Brody; David R Rubinow; Peter J Schmidt
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

7.  Change in health-related quality of life over the menopausal transition in a multiethnic cohort of middle-aged women: Study of Women's Health Across the Nation.

Authors:  Nancy E Avis; Alicia Colvin; Joyce T Bromberger; Rachel Hess; Karen A Matthews; Marcia Ory; Miriam Schocken
Journal:  Menopause       Date:  2009 Sep-Oct       Impact factor: 2.953

8.  The unique challenges of managing depression in mid-life women.

Authors:  Lorraine Dennerstein; Claudio N Soares
Journal:  World Psychiatry       Date:  2008-10       Impact factor: 49.548

9.  Associations between depressive symptoms, self-efficacy, eating styles, exercise and body mass index in women.

Authors:  Gretchen A Clum; Janet C Rice; Marsha Broussard; Carolyn C Johnson; Larry S Webber
Journal:  J Behav Med       Date:  2013-08-11

10.  Attitudes toward menopause in HIV-infected and at-risk women.

Authors:  Diana Hartel; Yungtai Lo; Carolyn Bauer; Nancy Budner; Andrea A Howard; Michelle Floris-Moore; Julia H Arnsten; Nanette Santoro; Ellie E Schoenbaum
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.